Bowel flora changes in humans receiving cefixime (CL 284,635) or cefaclor.
Twelve healthy young male subjects received either cefixime, a new oral cephalosporin (CL 284,635), or cefaclor (six subjects on each drug) orally for 2 weeks. In the case of cefixime, single daily doses of 400 mg were taken; with cefaclor, the dosage was 250 mg three times daily. Modest changes in...
Guardat en:
| Publicat a: | Antimicrob Agents Chemother |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society for Microbiology (ASM)
1987
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC174748/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3579262/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.31.3.443 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|
